Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Paysign Yönetim

Yönetim kriter kontrolleri 4/4

Paysign's CEO'su Mark Newcomer, Mar2006 tarihinde atandı, in görev süresi 18.58 yıldır. in toplam yıllık tazminatı $ 1.21M olup, şirket hissesi ve opsiyonları dahil olmak üzere 78.7% maaş ve 21.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 17.76% ine doğrudan sahiptir ve bu hisseler $ 34.63M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4 yıl ve 6.4 yıldır.

Anahtar bilgiler

Mark Newcomer

İcra Kurulu Başkanı

US$1.2m

Toplam tazminat

CEO maaş yüzdesi	78.7%
CEO görev süresi	18.6yrs
CEO sahipliği	17.8%
Yönetim ortalama görev süresi	4yrs
Yönetim Kurulu ortalama görev süresi	6.4yrs

Son yönetim güncellemeleri

Recent updates

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Sep 07

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

Jun 14

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

May 16

PaySign: A 'Backdoor' $2 Stagflation Play

Mar 29

Paysign: My Top Rebound Pick For 2022

Dec 28

Paysign: The Plasma Toll Booth

Sep 23

PaySign's Post-Pandemic Payoff

Sep 07

Why PaySign Is A Very Good Company

Dec 28

PaySign: Long-Term Story Still Intact

Dec 21

Paysign reports Q3 results

Nov 17

CEO Tazminat Analizi

Mark Newcomer'un ücretlendirmesi Paysign'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	US$8m
Mar 31 2024	n/a	n/a	US$7m
Dec 31 2023	US$1m	US$950k	US$6m
Sep 30 2023	n/a	n/a	US$2m
Jun 30 2023	n/a	n/a	US$1m
Mar 31 2023	n/a	n/a	US$1m
Dec 31 2022	US$3m	US$950k	US$1m
Sep 30 2022	n/a	n/a	US$420k
Jun 30 2022	n/a	n/a	-US$703k
Mar 31 2022	n/a	n/a	-US$1m
Dec 31 2021	US$963k	US$950k	-US$3m
Sep 30 2021	n/a	n/a	-US$7m
Jun 30 2021	n/a	n/a	-US$13m
Mar 31 2021	n/a	n/a	-US$12m
Dec 31 2020	US$1m	US$950k	-US$9m
Sep 30 2020	n/a	n/a	-US$3m
Jun 30 2020	n/a	n/a	US$6m
Mar 31 2020	n/a	n/a	US$8m
Dec 31 2019	US$1m	US$883k	US$7m
Sep 30 2019	n/a	n/a	US$6m
Jun 30 2019	n/a	n/a	US$4m
Mar 31 2019	n/a	n/a	US$3m
Dec 31 2018	US$875k	US$650k	US$3m
Sep 30 2018	n/a	n/a	US$2m
Jun 30 2018	n/a	n/a	US$2m
Mar 31 2018	n/a	n/a	US$2m
Dec 31 2017	US$552k	US$424k	US$2m

Tazminat ve Piyasa: Mark 'ın toplam tazminatı ($USD 1.21M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 1.46M ).

Tazminat ve Kazançlar: Mark 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Mark Newcomer (59 yo)

18.6yrs

Görev süresi

US$1,207,659

Tazminat

Mr. Mark R. Newcomer is a Co-Founder of PaySign, Inc., (formerly known as 3Pea International, Inc.) and serves as its President from January 24, 2024 and has been its Chief Executive Officer and Director s...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Mark Newcomer	Co-Founder	18.6yrs	US$1.21m	17.76% $ 34.0m
Jeffery Baker	CFO & Treasurer	3.7yrs	US$572.02k	0.35% $ 673.4k
Robert Strobo	General Counsel	6yrs	US$574.65k	0.39% $ 755.3k
Cosimo Cambi	Chief Operating Officer	less than a year	Veri yok	Veri yok
Brad Cunningham	Chief Technology Officer	3.3yrs	Veri yok	Veri yok
James McCroy	Executive Vice President of Strategic Development/IR	no data	Veri yok	Veri yok
Eric Trudeau	Chief Compliance Officer	6.7yrs	Veri yok	Veri yok
Dennis DiVenuta	Executive Vice President of Strategy & Corporate Development	6.6yrs	Veri yok	Veri yok
Alicia Ches	Director of Marketing	no data	Veri yok	Veri yok
Joan Herman	Executive VP of EFT Operations & Executive Director	3.7yrs	Veri yok	1.51% $ 2.9m
Matthew Lanford	Chief Payments Officer & Director	less than a year	Veri yok	0.25% $ 486.3k
Matthew Turner	President of Patient Affordability	4.3yrs	Veri yok	Veri yok

4.0yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim: PAYS 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Mark Newcomer	Co-Founder	18.6yrs	US$1.21m	17.76% $ 34.0m
Joan Herman	Executive VP of EFT Operations & Executive Director	5.9yrs	Veri yok	1.51% $ 2.9m
Matthew Lanford	Chief Payments Officer & Director	2.2yrs	Veri yok	0.25% $ 486.3k
Daniel Henry	Independent Director	6.4yrs	US$125.20k	0.15% $ 288.0k
Jeffrey Newman	Independent Director	1.8yrs	US$125.20k	0.056% $ 108.0k
Dennis Triplett	Non-Executive Independent Director	6.4yrs	US$125.20k	0.43% $ 828.0k
Alexander Goldberg	Member of Advisory Board	10yrs	Veri yok	Veri yok
Leonard Goodman	Member of Advisory Board	10yrs	Veri yok	Veri yok
Bruce Mina	Non-Executive Independent Director	6.6yrs	US$125.20k	0.45% $ 858.6k

6.4yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: PAYS 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.4 yıldır).

Paysign Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Independent Director exercised options to buy US$85k worth of stock.

PaySign, Inc., Annual General Meeting, May 03, 2024

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Co-Founder exercised options and sold US$71k worth of stock

CFO & Treasurer recently sold US$101k worth of stock

Recent updates

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

New minor risk - Insider selling

Consensus EPS estimates fall by 22%, revenue upgraded

Price target increased by 7.5% to US$6.58

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment improves as stock rises 34%

Paysign: Expect Rapid Growth In Its Pharma Business

Independent Director exercised options to buy US$85k worth of stock.

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 30%, revenue upgraded

PaySign, Inc., Annual General Meeting, May 03, 2024

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Price target increased by 14% to US$5.25

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc

Consensus EPS estimates increase by 25%

New major risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size

Consensus EPS estimates fall by 50%

PaySign, Inc. Reaffirms Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

Co-Founder exercised options and sold US$71k worth of stock

New minor risk - Market cap size

Consensus EPS estimates fall by 20%

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.006 loss in 1Q 2022)

Consensus EPS estimates increase by 36%

Price target increased by 13% to US$4.31

CFO & Treasurer recently sold US$101k worth of stock

PaySign, Inc. Elects Jeffrey B. Newman to Its Board of Directors

Consensus EPS estimates have been upgraded.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

PaySign, Inc. Provides Earnings Guidance for the Fiscal Year 2022

General Counsel exercised options to buy US$54k worth of stock.

The Recovery At PaySign Has Legs

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to US$3.75

PaySign, Inc. Provides Revenue Guidance for the Third and Fourth Quarter of 2022

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022

Price target decreased to US$3.44

Insufficient new directors

Price target decreased to US$3.44

Insufficient new directors

PaySign: A 'Backdoor' $2 Stagflation Play

Paysign: My Top Rebound Pick For 2022

Paysign: The Plasma Toll Booth

PaySign's Post-Pandemic Payoff

PaySign, Inc.(NasdaqCM:PAYS) dropped from Russell 2000 Defensive Index

PaySign, Inc. Provides Earnings Guidance for the Full Year 2021

Paysign, Inc. Announces Retirement of Joan M. Herman, as Chief Operating Officer

Why PaySign Is A Very Good Company

PaySign: Long-Term Story Still Intact

PaySign, Inc. and ImmunoTek Bio Centers LLC Collaborate in Support of COVID-19 Convalescent Plasma Collection